<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font32 { font-size : 32; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font26 { font-size : 26; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font32">(Â±.) </span>
   <span class="font26">conjunctivitis </span>
   <span class="font20">{border-style </span>
   <span class="font20">symptoms </span>
   <span class="font19">px;} </span>
   <span class="font19">viral </span>
   <span class="font18">#ffffff;} </span>
   <span class="font18">acute </span>
   <span class="font18">patients </span>
   <span class="font17">evaluation </span>
   <span class="font17">treatment </span>
   <span class="font16">group </span>
   <span class="font16">eye </span>
   <span class="font16">tears </span>
   <span class="font15">artificial </span>
   <span class="font15">clinical </span>
   <span class="font15">study </span>
   <span class="font15">demonstrated </span>
   <span class="font15">ketorolac </span>
   <span class="font14">&amp;gt;. </span>
   <span class="font14">(.%) </span>
   <span class="font14">groups </span>
   <span class="font14">topical </span>
   <span class="font14">diclofenac </span>
   <span class="font14">inflammatory </span>
   <span class="font14">px; </span>
   <span class="font14">report </span>
   <span class="font14">signs </span>
   <span class="font14">{font-family </span>
   <span class="font13">IL- </span>
   <span class="font13">ciprofloxacin </span>
   <span class="font13">difference </span>
   <span class="font13">font-size </span>
   <span class="font13">keratoconjunctivitis </span>
   <span class="font13">prednisolone </span>
   <span class="font13">Table </span>
   <span class="font13">adenoviral </span>
   <span class="font13">allergic </span>
   <span class="font13">conjunctivitis, </span>
   <span class="font13">conjunctivitis. </span>
   <span class="font13">double; </span>
   <span class="font13">epidemic </span>
   <span class="font13">sodium </span>
   <span class="font13">statistical </span>
   <span class="font12">Conjunctivitis </span>
   <span class="font12">Group </span>
   <span class="font12">Med </span>
   <span class="font12">border-color </span>
   <span class="font12">border-width </span>
   <span class="font12">compared </span>
   <span class="font12">following </span>
   <span class="font12">improvement </span>
   <span class="font12">patients, </span>
   <span class="font12">prevalence </span>
   <span class="font12">randomized </span>
   <span class="font12">received </span>
   <span class="font12">solid; </span>
   <span class="font12">{font-style </span>
   <span class="font12">{font-weight </span>
   <span class="font12">&amp;lt;. </span>
   <span class="font12">Hospital </span>
   <span class="font12">Median </span>
   <span class="font12">NSAID </span>
   <span class="font12">anti-inflammatory </span>
   <span class="font12">associated </span>
   <span class="font12">bold </span>
   <span class="font12">care </span>
   <span class="font12">common </span>
   <span class="font12">conjunctival </span>
   <span class="font12">courier; </span>
   <span class="font12">em; </span>
   <span class="font12">however, </span>
   <span class="font12">medication </span>
   <span class="font12">pt;} </span>
   <span class="font12">significant </span>
   <span class="font12">study, </span>
   <span class="font12">treated </span>
   <span class="font12">trend </span>
   <span class="font12">use </span>
   <span class="font12">using </span>
  </p>
 </body>
</html>
